Filing Details
- Accession Number:
- 0001209191-23-058709
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-14 20:58:32
- Reporting Period:
- 2023-12-13
- Accepted Time:
- 2023-12-14 20:58:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1231457 | Genelux Corp | GNLX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1939103 | John Thomas | C/O Genelux Corporation 2625 Townsgate Road, Suite 230 Westlake Village CA 91361 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-12-13 | 7,073 | $13.23 | 465,387 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-12-13 | 1,927 | $13.93 | 463,460 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The weighted average sale price for the transaction reported was $13.2261, and the range of prices were between $12.76 and $13.75. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- The weighted average sale price for the transaction reported was $13.9277, and the range of prices were between $13.80 and $14.13. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.